ASML Chip Tools Now Build Medical Sensors at Scale

The same cutting-edge machines that create the world's most advanced computer chips are getting an unexpected second job in medical technology. IMEC researchers have proven that ASML's extreme ultraviolet lithography systems can mass-produce nanopores for molecular sensing applications, marking a significant breakthrough in biomedical device manufacturing.

For those unfamiliar with the tech, nanopores are incredibly tiny holes measured in nanometers that can detect individual molecules as they pass through. Think of them as molecular-scale security checkpoints that can identify specific proteins, DNA sequences, or other biological markers. Until now, creating these sensors at commercial scale has been challenging and expensive. ASML's EUV machines, which typically cost upward of $200 million and are used by companies like TSMC and Intel to manufacture cutting-edge processors, can now fabricate entire wafers full of these nanoscale sensors with unprecedented precision.

The value proposition here is compelling for biotech companies and medical device manufacturers. Instead of slow, expensive production methods that limit nanopore availability, they can leverage the same mass production techniques that make modern electronics affordable. This means faster development of portable diagnostic devices, more accessible DNA sequencing tools, and potentially cheaper point-of-care testing equipment.

Who should pay attention to this development? Medical device startups, diagnostic equipment manufacturers, and research institutions working on next-generation biosensors will find this particularly relevant. While individual companies won't be buying EUV machines for in-house production, foundries offering biomedical fabrication services could emerge as key players. The semiconductor industry's proven ability to scale production while driving down costs could transform how we approach molecular diagnostics in 2026 and beyond.